Hyperthermic intraperitoneal chemotherapy enhances antitumor effects on ovarian cancer through immune-mediated cancer stem cell targeting

Hyperthermic intraperitoneal chemotherapy enhances antitumor effects on ovarian cancer through immune-mediated cancer stem cell targeting

Purpose We aimed to determine the effects and possible mechanisms of hyperthermic intraperitoneal chemotherapy (HIPEC) in targeting ovarian cancer stem-like cells (CSCs). Methods Murine ovarian cancer cell lines presenting CSC surface markers were grown intraperitoneally in both immunocompetent and...

Full description

Bibliographic Details
Main Authors:	Chao-Chih Wu, Yun-Ting Hsu, Chih-Long Chang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-01-01
Series:	International Journal of Hyperthermia
Subjects:	hyperthermia hipec ((hyperthermic intraperitoneal chemotherapy) macrophage cancer stem-like cells anti-tumor immunity ovarian cancer
Online Access:	http://dx.doi.org/10.1080/02656736.2021.1945688

Similar Items

The evolution of hyperthermic intraperitoneal chemotherapy in the setting of advanced ovarian cancer
by: Quindlen, Kevin John
Published: (2019)

The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
by: Guyu Zhang, et al.
Published: (2019-04-01)

Hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
by: Jieun Ko, et al.
Published: (2021-09-01)

Effect of hyperthermia on improving neutrophil restoration after intraperitoneal chemotherapy
by: Wan-Chun Huang, et al.
Published: (2019-01-01)

Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients
by: Wu-yun Wang, et al.
Published: (2021-01-01)

Feasibility and safety of neoadjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in patients with advanced stage ovarian cancer: a single-center experience
by: Gao T, et al.
Published: (2019-07-01)

A Four-Inflow Construction to Ensure Thermal Stability and Uniformity during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Rats
by: Daan R. Löke, et al.
Published: (2020-11-01)

Anesthesiological support of cytoreducative operations using hyperthermic intraperitoneal chemotherapy (hipec) in patients with ovaryan cancer
by: D. D. Morikov, et al.
Published: (2019-11-01)

Data on the quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies: does it concern patients with gastric cancer?
by: Skierucha Malgorzata, et al.
Published: (2017-12-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)
by: W. J. Koemans, et al.
Published: (2019-05-01)

OUR EXPERIENCE OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR PATIENTS WITH ADVANCED GASTRIC CANCER
by: A. D. Kaprin, et al.
Published: (2016-01-01)

The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines
by: Roxan F.C.P.A. Helderman, et al.
Published: (2020-07-01)

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
by: McKayla J. Riggs, et al.
Published: (2020-01-01)

The Controversy of Intraperitoneal Hyperthermic Chemotherapy for Ovarian Cancer
by: Lucian ALECU, et al.
Published: (2020-12-01)

Multicystic peritoneal mesothelioma treated with cytoreductive surgery followed or not by hyperthermic intraperitoneal chemotherapy: results from a large multicentric cohort
by: Vahan Kepenekian, et al.
Published: (2021-01-01)

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer
by: Andrea Jewell, et al.
Published: (2018-09-01)

Efficacy of hyperthermic intraperitoneal chemotherapy in patients with epithelial ovarian cancer: a meta-analysis
by: Qiwen Wu, et al.
Published: (2019-01-01)

Lobaplatin in Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: Safety and Efficacy Profiles
by: Zhong Y, et al.
Published: (2020-06-01)

Role of intraperitoneal chemotherapy in gastric cancer
by: Amir Parray, et al.
Published: (2021-03-01)

Dense hyperthermic intraperitoneal chemotherapy with cisplatin in patients with stage III serous epithelial ovarian cancer: a retrospective study
by: Xiaoli He, et al.
Published: (2021-06-01)

Association between pelvic exenteration and hyperthermic intraperitoneal chemotherapy for rectal cancer
by: Nicolae Bacalbasa, et al.
Published: (2021-06-01)

Cytoreductive surgery and HIPEC (hyperthermic intraperitoneal chemotherapy) in combined treatment of ovarian cancer: time for the beginning of personalized therapy?
by: Yarema Roman, et al.
Published: (2019-09-01)

MODERN STRATEGY IN TREATMENT OF PERITONEAL CARCINOMATOSIS
by: A. A. Zakharenko, et al.
Published: (2017-12-01)

Treatment of Krukenberg tumor with hyperthermic intraperitoneal chemotherapy: A report of three cases
by: Li-Yung Chen, et al.
Published: (2016-01-01)

Efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of malignant ascites
by: Jie Jiao, et al.
Published: (2020-07-01)

Anesthetic implications in hyperthermic intraperitoneal chemotherapy
by: Nishkarsh Gupta, et al.
Published: (2019-01-01)

Adverse Reaction of HIPEC Combined with Intravenous Chemotherapy on Ovarian Cancer Patients
by: YANG Jing, et al.
Published: (2019-12-01)

Is Palliative Laparoscopic Hyperthermic Intraperitoneal Chemotherapy Effective in Patients with Malignant Hemorrhagic Ascites
by: Louis de Mestier, et al.
Published: (2012-04-01)

Hyperthermic intraoperative thoracoabdominal chemotherapy for stage IVB epithelial ovarian carcinoma
by: Alexandre Brind'Amour, et al.
Published: (2020-11-01)

Experience of applying cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian teratoma with malignant transformation and peritoneal dissemination
by: Yu HH, et al.
Published: (2019-01-01)

Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study
by: Leonardo Solaini, et al.
Published: (2019-03-01)

Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials
by: Sun Jingxu, et al.
Published: (2012-11-01)

The addition of sodium thiosulphate to hyperthermic intraperitoneal chemotherapy with cisplatin in ovarian cancer
by: Kate Glennon, et al.
Published: (2021-08-01)

Drain site enterocutaneous fistula after hyperthermic intraperitoneal chemotherapy
by: Navin Kumar, et al.
Published: (2021-01-01)

Hyperthermic Intraperitoneal Chemotherapy: A Critical Review
by: Wim Ceelen, et al.
Published: (2021-06-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
by: Loss Martin, et al.
Published: (2004-06-01)

A pilot randomised clinical trial comparing desflurane anaesthesia vs total intravenous anaesthesia, for changes in haemodynamic, inflammatory and coagulation parameters in patients undergoing hyperthermic intraperitoneal chemotherapy
by: Anuja Pandit, et al.
Published: (2020-01-01)

Current Situation of Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinoma
by: ZHAN Hongjie, et al.
Published: (2021-04-01)

Does hyperthermic intraoperative chemotherapy lead to improved outcomes in patients with ovarian cancer? A single center cohort study in 111 consecutive patients
by: Warschkow Rene, et al.
Published: (2012-06-01)

IS HIPEC BENEFICIAL IN PLATINUM RESISTANT RELAPSED OVARIAN CANCER?
by: Nicolae Bacalbasa, et al.
Published: (2019-09-01)

Cannot write session to /tmp/vufind_sessions/sess_37ss91kgpdfj1nevjcnhcekkdb